End to End Platform
Palo Alto Networks provides an End to End Platform. It integrates together to offer organizations a better Security Posture against Ransomware and any other threat. This is done through a combination of Palo Alto Networks Next-Generation Firewall. The firewall is an 8 years consecutive Leader in Gartner’s Enterprise Firewall Magic Quadrant, and Cortex XDR Endpoint is the leading solution in Detection & Response rated by Mitre ATT&CK.
The Single Pass Parallel Passthrough (SP3) Architecture allows organizations to seamlessly enable new Security Services. The Security Services is able to achieve better ROI and product longevity as the threat landscape changes. It’s also the only NGFW in the market that has built-in Machine Learning capabilities to provide protection against Patient Zero without relying on Signature. Besides, it has the fastest update time from Threat Intelligence (up to seconds). Most of the similar solutions still take minutes or days to deliver Security Updates.
Cortex XDR – Palo Alto Networks
Cortex XDR Agent takes a multi-method prevention approach against all attacks be it Malware or Exploit. It does not solely rely on Signature to provide protection, but rather uses Behaviour. For example, Exploit Technique and Malware Local Analysis. Its built-in APT capability allows it to share Threat Intelligence from Palo Alto Networks’ largest Threat Intelligence Database. Also, it’s Signal the deployed NGFW for a correlated update. This is typically a manual process for most Organizations that employ a silo solution in each area.
Ipenet Solutions provides End to End service for all our customers. We can start off by doing a Threat Assessment in your organization and provide a proposed solution architecture that can address the gap. We are also capable of giving you a Best Practice Assessment Report over time by partnering with Palo Alto Networks. This means to ensure your Security Posture can be validated and adhere to the best possible manner that adheres to Vendor, 3rd party Best Practice.